Revolutionary approach for treating glioblastoma works with human cells
In a rapid-fire series of breakthroughs in just under a year, researchers at the University of North Carolina at Chapel Hill have made another stunning advance in the development of an effective treatment for glioblastoma, a common and aggressive brain cancer. The work, published in the Feb. 1 issue of Science Translational Medicine, describes how human stem cells, made from human skin cells, can hunt down and kill human brain cancer, a critical and monumental step toward clinical trials – and real treatment.
Last year, the UNC-Chapel Hill team, led by Shawn Hingtgen, an assistant professor in the Eshelman School of Pharmacy and member of the Lineberger Comprehensive Cancer Center, used the technology to convert mouse skin cells to stem cells that could home in on and kill human brain cancer, increasing time of survival 160 to 220 percent, depending on the tumor type. Now, they not only show that the technique works with human cells but also works quickly enough to help patients, whose median survival is less than 18 months and chance of surviving beyond two years is 30 percent.
“Speed is essential,” Hingtgen said. “It used to take weeks to convert human skin cells to stem cells. But brain cancer patients don’t have weeks and months to wait for us to generate these therapies. The new process we developed to create these stem cells is fast enough and simple enough to be used to treat a patient.”
Surgery, radiation and chemotherapy are the standard of care for glioblastoma, and that hasn’t changed in three decades. In months, the tumor comes back in almost every single patient, invariably sending tiny tendrils out into the surrounding brain tissue. Drugs can’t reach them, and surgeons can’t see them, so it’s almost impossible to remove all of the cancer, explained Ryan Miller, a coauthor of the study and neuropathologist at UNC Hospitals and associate professor at the UNC School of Medicine.
“We desperately need something better,” said Hingtgen.
The key to Hingtgen’s treatment is “skin flipping,” a technology for creating neural stem cells from skin cells that won a Nobel Prize in 2012. The first step is to harvest fibroblasts — skin cells responsible for producing collagen and connective tissue — from the patient and reprogram those cells to become what are called induced neural stem cells, which have an innate ability to home in on cancer cells in the brain.
But by themselves, stem cells can only find a tumor and bump up against it – not kill it – so the team had to engineer stem cells that could carry therapeutic agents that the cells can launch at the tumor to kill it.
Hingtgen’s stem cells can carry a protein that activates an inert substance called a prodrug that is given to the patient. The cells can then generate a small halo of drug that is located just around the stem cell, rather than it being circulated throughout the patient’s body, reducing unwanted side effects.
“We’re one to two years away from clinical trials, but for the first time, we showed that our strategy for treating glioblastoma works with human stem cells and human cancers,” said Hingtgen. “This is a big step toward a real treatment – and making a real difference.”
Receive an email update when we add a new GLIOBLASTOMA article.
The Latest on: Glioblastoma
via Google News
The Latest on: Glioblastoma
- miR-548x and miR-4698 controlled cell proliferation by affecting the PI3K/AKT signaling pathway in Glioblastoma cell lineson January 31, 2020 at 2:54 am
Glioblastoma multiforme (GBM) is the most aggressive and prevalent form of brain tumor cancers that originate from glial cells. This study proposed to investigate the effect of miR-548x and miR-4698 ...
- The Importance of Combination Immune Therapy in Orthotopic Murine Glioblastomaon January 30, 2020 at 8:07 pm
Connor Liu, medical student, Washington University School of Medicine, discusses the importance of combination immunotherapy in orthotopic murine glioblastoma. With a historically aggressive and ...
- RBL1 (p107) functions as tumor suppressor in glioblastoma and small-cell pancreatic neuroendocrine carcinoma in Xenopus tropicalison January 30, 2020 at 9:43 am
McLendon R, Friedman A, Bigner D, Van Meir EG, Brat DJ, Mastrogianakis GM, et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008;455:1061–8.
- Glioblastoma Alters Synaptic Function to Promote Tumor Growthon January 30, 2020 at 5:28 am
Scientists at Baylor College of Medicine report on studies in mice, which indicate that glioblastoma brain tumors impact on the activity of neighboring neurons, promoting a vicious cycle that alters ...
- Brain organoids reveal glioblastoma originson January 29, 2020 at 4:55 am
They discovered that glioblastomas do not appear to originate from a single cell type—what other researchers have called a "glioblastoma stem cell"—but instead arise from multiple kinds of seed cells, ...
- Novocure Announces National Reimbursement in Israel for Optune® in Combination with Temozolomide for the Treatment of Newly Diagnosed Glioblastomaon January 29, 2020 at 12:27 am
ST. HELIER, Jersey--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) announced today that the State of Israel Ministry of Health has added Optune in combination with temozolomide to the Israeli medical ...
- Fishing tournament aims to benefit Port St. Lucie teen, Kyle Vericella, battling glioblastomaon January 28, 2020 at 8:28 pm
The new Treasure Coast Snook Challenge fishing tournament this weekend will help raise money for a local teenager battling glioblastoma.
- Beaumont receives $1.6 million from NIH to study glioblastomaon January 28, 2020 at 12:28 pm
One of your neighbors posted in Health & Fitness. Click through to read what they have to say. (The views expressed in this post are the author’s own.) ...
- Glioblastoma Multiforme Market Positioning And Growing Market Share Worldwide Till 2026on January 27, 2020 at 1:40 am
Glioblastoma multiforme is a type of cancer that is aggressive in nature and develops within the brain. The usual symptoms of glioblastoma multiforme include headache, personality changes, and nausea.
via Bing News